These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

349 related articles for article (PubMed ID: 33816399)

  • 1. Kawasaki Disease Shock Syndrome in Japan and Comparison With Multisystem Inflammatory Syndrome in Children in European countries.
    Suzuki J; Abe K; Matsui T; Honda T; Yasukawa K; Takanashi JI; Hamada H
    Front Pediatr; 2021; 9():625456. PubMed ID: 33816399
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of COVID-19-associated multisystem inflammatory syndrome in children (MIS-C) and Kawasaki disease shock syndrome: case reports and literature review.
    Lee S; Kim D; Kim BJ; Rhim JW; Lee SY; Jeong DC
    J Rheum Dis; 2023 Oct; 30(4):272-277. PubMed ID: 37736588
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Similarities and Differences between Multisystem Inflammatory Syndrome in Children (MIS-C) and Kawasaki Disease Shock Syndrome.
    Lee J; Kim BJ; Cho KS; Rhim JW; Lee SY; Jeong DC
    Children (Basel); 2023 Sep; 10(9):. PubMed ID: 37761488
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kawasaki Disease Shock Syndrome vs Classical Kawasaki Disease: A Meta-analysis and Comparison With SARS-CoV-2 Multisystem Inflammatory Syndrome.
    Lamrani L; Manlhiot C; Elias MD; Choueiter NF; Dionne A; Harahsheh AS; Portman MA; McCrindle BW; Dahdah N
    Can J Cardiol; 2021 Oct; 37(10):1619-1628. PubMed ID: 34090979
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kawasaki disease shock syndrome: clinical characteristics and possible use of IL-6, IL-10 and IFN-γ as biomarkers for early recognition.
    Li Y; Zheng Q; Zou L; Wu J; Guo L; Teng L; Zheng R; Jung LKL; Lu M
    Pediatr Rheumatol Online J; 2019 Jan; 17(1):1. PubMed ID: 30611297
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Laboratory parameters between multisystem inflammatory syndrome in children and Kawasaki disease.
    Zhou C; Zhao Y; Wang X; Huang Y; Tang X; Tang L
    Pediatr Pulmonol; 2021 Dec; 56(12):3688-3698. PubMed ID: 34583417
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical manifestations of Kawasaki disease shock syndrome: a case-control study.
    Chen PS; Chi H; Huang FY; Peng CC; Chen MR; Chiu NC
    J Microbiol Immunol Infect; 2015 Feb; 48(1):43-50. PubMed ID: 23927822
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Similarities and differences between multiple inflammatory syndrome in children associated with COVID-19 and Kawasaki disease: clinical presentations, diagnosis, and treatment.
    Zhang QY; Xu BW; Du JB
    World J Pediatr; 2021 Aug; 17(4):335-340. PubMed ID: 34013488
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kawasaki disease shock syndrome: Unique and severe subtype of Kawasaki disease.
    Gamez-Gonzalez LB; Moribe-Quintero I; Cisneros-Castolo M; Varela-Ortiz J; Muñoz-Ramírez M; Garrido-García M; Yamazaki-Nakashimada M
    Pediatr Int; 2018 Sep; 60(9):781-790. PubMed ID: 29888440
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kawasaki Disease Shock Syndrome in the Eastern Region of Saudi Arabia: Case Series.
    Busaleh F; AlKadhem SM; Albarrak A; Almubarak AA; Aldandan MM; Almajed JM; Alabdullah MA; Almulaifi LF
    Cureus; 2021 May; 13(5):e14961. PubMed ID: 34123658
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kawasaki disease shock syndrome in the COVID-19 pandemic.
    Gámez-González LB; Ramírez-López MJ; Colmenero-Rascón M; Yamazaki-Nakashimada MA
    Cardiol Young; 2022 Mar; 32(3):506-507. PubMed ID: 34278987
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Kawasaki disease and multisystem inflammatory syndrome in children. Differences, and similarities in a pediatric center in Mexico].
    García-Domínguez M; Anaya-Enríquez N; Luque-Vega L; Canizales-Muñoz S; Flores R; Tostado-Morales E; Torres CG; Melchor V; Quibrera J; Velázqueaz-Ríos C; León-Ramírez ÁR; Carreón-Guerrero JM; Llausás-Magaña E
    Rev Alerg Mex; 2023 Jun; 70(2):80-88. PubMed ID: 37566771
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical Subphenotypes of Multisystem Inflammatory Syndrome in Children: An EHR-based cohort study from the RECOVER program.
    Rao S; Jing N; Liu X; Lorman V; Maltenfort M; Schuchard J; Wu Q; Tong J; Razzaghi H; Mejias A; Lee GM; Pajor NM; Schulert GS; Thacker D; Jhaveri R; Christakis DA; Bailey LC; Forrest CB; Chen Y
    medRxiv; 2022 Sep; ():. PubMed ID: 36203555
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Kawasaki Disease Shock Syndrome Presented with Giant Coronary Artery Dilatation - Presentation of Two Cases and a Literature Review.
    Bejiqi R; Pajaziti N; Agushi S
    Acta Inform Med; 2022 Sep; 30(3):253-256. PubMed ID: 36311151
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characteristics of Kawasaki Disease Patients during the COVID-19 Pandemic in Japan: A Single-Center, Observational Study.
    Shimizu S; Ayusawa M; Go H; Nakazaki K; Namiki H; Kasuga Y; Nishimura K; Kanezawa K; Morohashi T; Morioka I
    Children (Basel); 2021 Oct; 8(10):. PubMed ID: 34682178
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of Characteristics and Outcomes of Multisystem Inflammatory Syndrome, Kawasaki Disease and Toxic Shock Syndrome in Children.
    Klavina L; Smane L; Kivite-Urtane A; Vasilevska L; Davidsone Z; Smitins E; Gardovska D; Lubaua I; Roge I; Pucuka Z; Meiere A; Pavare J
    Medicina (Kaunas); 2023 Mar; 59(3):. PubMed ID: 36984627
    [No Abstract]   [Full Text] [Related]  

  • 17. Severe manifestations of SARS-CoV-2 in children and adolescents: from COVID-19 pneumonia to multisystem inflammatory syndrome: a multicentre study in pediatric intensive care units in Spain.
    García-Salido A; de Carlos Vicente JC; Belda Hofheinz S; Balcells Ramírez J; Slöcker Barrio M; Leóz Gordillo I; Hernández Yuste A; Guitart Pardellans C; Cuervas-Mons Tejedor M; Huidobro Labarga B; Vázquez Martínez JL; Gutiérrez Jimeno M; Oulego-Erróz I; Trastoy Quintela J; Medina Monzón C; Medina Ramos L; Holanda Peña MS; Gil-Antón J; Sorribes Ortí C; Flores González JC; Hernández Palomo RM; Sánchez Ganfornina I; Fernández Romero E; García-Besteiro M; López-Herce Cid J; González Cortés R;
    Crit Care; 2020 Nov; 24(1):666. PubMed ID: 33243303
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Kawasaki Disease and Multisystem Inflammatory Syndrome in Children: Common Inflammatory Pathways of Two Distinct Diseases.
    Noval Rivas M; Arditi M
    Rheum Dis Clin North Am; 2023 Aug; 49(3):647-659. PubMed ID: 37331738
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Defining Kawasaki disease and pediatric inflammatory multisystem syndrome-temporally associated to SARS-CoV-2 infection during SARS-CoV-2 epidemic in Italy: results from a national, multicenter survey.
    Cattalini M; Della Paolera S; Zunica F; Bracaglia C; Giangreco M; Verdoni L; Meini A; Sottile R; Caorsi R; Zuccotti G; Fabi M; Montin D; Meneghel A; Consolaro A; Dellepiane RM; Maggio MC; La Torre F; Marchesi A; Simonini G; Villani A; Cimaz R; Ravelli A; Taddio A;
    Pediatr Rheumatol Online J; 2021 Mar; 19(1):29. PubMed ID: 33726806
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of Clinical Features and Inflammatory Markers between Kawasaki Disease Shock Syndrome and Kawasaki Disease without Shock: A Meta-Analysis.
    Zhang H; Zheng Q; Li F
    J Healthc Eng; 2021; 2021():1486089. PubMed ID: 34966519
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.